サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1584093

GI便検査市場：検査タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024-2032年予測

GI Stool Testing Market, By Test Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 316 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
GI便検査市場：検査タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024-2032年予測
出版日: 2024年10月26日
発行: AnalystView Market Insights
ページ情報: 英文 316 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

GI便検査市場規模は2023年に5億5,020万米ドルとなり、2024年から2032年にかけてCAGR 7.80%で拡大

GI便検査市場-市場力学

感染症および消化器疾患の有病率の増加と予防診断の必要性が市場需要を促進する見込み

過敏性腸症候群（IBS）、クローン病、潰瘍性大腸炎、セリアック病、大腸がんなどの消化器疾患の世界の有病率の増加は、GI便検査のような診断ツールに対する需要を促進し、それによって市場成長を後押ししています。これらの疾患は、適切な診断とモニタリングのために便分析を必要とすることが多いです。細菌、ウイルス、寄生虫によって引き起こされる感染性消化器疾患の有病率の増加は、便検査の必要性を煽っています。旅行、世界化、抗生物質耐性株の蔓延がこの需要に寄与しています。予防医療対策と定期的な健康診断に対する個人の意識の高まりが、GI便検査の成長を促進しています。例えば、便潜血検査（FOBT）は、最も予防可能ながんの一つである大腸がんの早期発見のために広く推奨されています。

市販の家庭用GI便検査キットが利用できるようになったことで、自宅にいながら消化器系の健康状態をモニターすることが容易になった。EverlywellやViomeのような企業がこの動向を普及させ、便検査をより多くの消費者が利用できるようにしています。世界中のいくつかのヘルスケア機関は、大腸がんの早期発見のためのスクリーニングプログラムを実施しています。このことが、特にがん罹患率の高い国々で、FOBTや便免疫化学検査（FIT）のような便ベースの検査の採用を促進しています。

GI便検査市場-主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約7.80%のCAGRで毎年成長すると予測されています。

検査タイプ別では、細菌感染症の高い発生率に起因して、細菌検査セグメントが2023年に最大の市場シェアを示すと予測されました。

用途別では、細菌およびウイルス感染症による障害のため、感染症分野が2023年の主要用途分野でした。

エンドユーザー別では、がん、腸疾患などの治療ニーズの高まりにより、病院・診療所が2023年の主要エンドユーザーでした。

地域別では、北米が、継続的な技術進歩と認知度により、2023年の主要収益源でした。

GI便検査市場-セグメンテーション分析：

GI便検査の世界市場は、検査タイプ、用途、エンドユーザー、地域に基づいて区分されます。

細菌検査、便バイオマーカー検査、潜血検査、その他。細菌検査分野が市場を独占しています。技術革新と高度なスクリーニング方法の増加が同分野の成長を促進しています。

用途別では、感染症、炎症性腸疾患、胃食道逆流症（GERD）、がん、その他に分類されます。感染症分野が市場を独占しています。ウイルス感染症の有病率の増加と便ベースの検査ニーズが市場の成長を促進しています。

市場はエンドユーザー別に、病院・診療所、診断センター、在宅医療、その他の4つに分類されます。病院・診療所セグメントは市場を独占しており、予測期間中も高い優位性を維持すると予想されます。GI疾患、がんの早期発見の必要性、高度なスクリーニングの利点がセグメントの成長を補完しています。

GI便検査市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。北米は、高度なヘルスケアインフラ、消化器疾患の高い有病率、予防的健康対策に対する意識の広まりにより、世界のGI検便市場で大きなシェアを占めています。米国は大腸がんの罹患率が最も高い国の一つであり、早期発見のために定期的なスクリーニングプログラムが実施されています。欧州では、英国、ドイツ、フランスを含むいくつかの欧州諸国が大腸がんの国家スクリーニング・プログラムを実施しており、FOBTやFITのような便ベースの検査の需要を牽引しています。アジア太平洋地域は、GI便検査市場において最も速い成長が期待されています。この背景には、消化器疾患の罹患率の増加、ヘルスケアインフラの拡大があります。

GI便検査市場-競合情勢：

GI便検査市場の競合情勢は緩やかです。企業は、GI便検査の感度と特異度を向上させるため、PCR、次世代シークエンシング、マイクロアレイ技術を含む分子診断の進歩に注力しています。腸内細菌叢（マイクロバイオーム）に関する研究の活発化が新製品開発につながり、複数の企業が腸内細菌を分析してより広範な健康に関する知見を得るための検査を提供しています。市場開発企業はまた、病院や診療所におけるポイント・オブ・ケアのニーズに対応し、より迅速な結果を提供する迅速診断検査の開発も進めています。

2022年12月、Shineco, Inc.は、革新的かつ先進的なin-situ便検体サンプリング装置の米国FDA承認とUSPTO特許保護を取得しました。

2022年、Prenetics GroupはNew Horizon Healthと提携し、ColoClear by Circleという新しいツールを発売。

目次

第1章 消化管便検査市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 消化管便検査の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 消化管便検査業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 消化管便検査市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 消化管便検査市場情勢

  • 消化管便検査市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 消化管便検査市場- 検査タイプ別

  • 概要
    • 検査タイプ別セグメントシェア分析
    • 細菌検査
    • 便バイオマーカー検査
    • 潜血検査
    • その他

第8章 消化管便検査市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 感染症
    • 炎症性腸疾患
    • 胃食道逆流症（GERD）
    • がん
    • その他

第9章 消化管便検査市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院・診療所
    • 診断センター
    • ホームケア
    • その他

第10章 消化管便検査市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- GI便検査業界

  • 競合ダッシュボード
  • 企業プロファイル
    • AdvaCare Pharma
    • Biomrieux Inc
    • Bio-Rad Laboratories
    • Cardinal Health
    • Cenogenics Corporation
    • CTK Biotech Inc.
    • Diasorin SPA
    • Eiken Chemical Co. Ltd.
    • Epitope Diagnostics Inc.
    • Exact Sciences Corp.
    • F. Hoffmann-La Roche Ltd.
    • Genova Diagnostics
    • Meridian Bioscience Inc
    • Pinnacle BioLabs
    • Prenetics Group Limited
    • QIAGEN
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV4083

REPORT HIGHLIGHT

GI Stool Testing Market size was valued at USD 550.20 Million in 2023, expanding at a CAGR of 7.80% from 2024 to 2032.

GI (Gastrointestinal) stool testing involves the analysis of a person's stool or feces to assess their digestive health, identify infections, and detect any underlying gastrointestinal (GI) issues. It is a non-invasive diagnostic tool used by healthcare professionals to evaluate a variety of conditions.

GI Stool Testing Market- Market Dynamics

Growing prevalence of infectious and gastrointestinal disorders and need for preventive diagnostics is expected to propel market demand

The global increasing prevalence of gastrointestinal disorders such as irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis, celiac disease, and colorectal cancer is driving demand for diagnostic tools like GI stool testing, thereby boosting market growth. These conditions often require stool analysis for proper diagnosis and monitoring. The growing prevalence of infectious gastrointestinal diseases caused by bacteria, viruses, and parasites fuels the need for stool testing. Travel, globalization, and the spread of antibiotic-resistant strains contribute to this demand. Increasing awareness of preventive healthcare measures and regular health screenings among individuals is driving the growth of GI stool tests. For instance, fecal occult blood tests (FOBT) are widely recommended for early detection of colorectal cancer, one of the most preventable cancers.

The availability of over the counter at-home GI stool testing kits has made it easier for individuals to monitor their digestive health from the comfort of their homes. Companies like Everlywell and Viome are popularizing this trend, making stool tests more accessible to a wider consumer base. Several healthcare organizations around the world are implementing screening programs for early detection of colorectal cancer. This drives the adoption of stool-based tests like FOBT and fecal immunochemical tests (FIT), especially in countries with high cancer incidence rates.

GI Stool Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.80% over the forecast period (2024-2032)

Based on Test Type segmentation, the bacteria tests segment was predicted to show maximum market share in the year 2023, owing to its high incidence of bacterial infections.

Based on Application segmentation, infectious diseases segment was the leading Application segment in 2023, due to the disorders cause by bacteria, and viral infections.

Based on End User segmentation, hospital & clinics segment was the leading End User segment in 2023, due to the growing need for treatment in disease like cancer, bowel disease, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the continuous tech advancement & awareness.

GI Stool Testing Market- Segmentation Analysis:

Global GI Stool Testing Market is segmented on the basis of Test Type, Application, End User, and Region.

The market is divided into four categories based on Test Type: bacteria tests, fecal biomarker tests, occult blood tests, and others. The bacteria tests segment dominates the market. Increasing tech innovations and advanced screening methods are promoting segment growth.

The market is divided into five categories based on Application: infectious diseases, inflammatory bowel disease, gastroesophageal reflux disease (GERD), cancer, and others. The infectious disease segment dominates the market. The increasing prevalence of viral infections and the need for stool-based tests is fueling market growth.

The market is divided into four categories based on End User: hospital & clinics, diagnostic centers, homecare, and others. The hospital & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The need for early detection of GI diseases, cancer, advanced screening benefits are supplementing segment growth.

GI Stool Testing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a sizable share of the global GI stool testing market due to advanced healthcare infrastructure, high prevalence of gastrointestinal disorders, and widespread awareness of preventive health measures. The U.S. has one of the highest rates of colorectal cancer, with routine screening programs in place for early detection. In Europe, Several European countries, including the U.K., Germany, and France, have national screening programs for colorectal cancer, driving demand for stool-based tests like FOBT and FIT. The Asia-Pacific region is expected to experience the fastest growth in the GI stool testing market. This is driven by an increasing incidence of gastrointestinal diseases, expanding healthcare infrastructure.

GI Stool Testing Market- Competitive Landscape:

The competitive landscape of the GI Stool Testing market is moderately competitive in nature. Companies are focusing on advancing molecular diagnostics, including PCR, next-generation sequencing, and microarray technologies, to improve the sensitivity and specificity of GI stool tests. Increased research into the gut microbiome has led to new product development, with several companies offering tests that analyze gut bacteria for broader health insights. Market players are also developing rapid diagnostic tests that provide faster results, catering to point-of-care needs in hospitals and clinics.

In December 2022, Shineco, Inc. received US FDA approval and USPTO patent safeguarding for its innovative & advanced in-situ fecal specimen sampling device.

In 2022, Prenetics Group collaborated with New Horizon Health to launch new tool called ColoClear by Circle.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GI STOOL TESTING MARKET KEY PLAYERS

  • AdvaCare Pharma
  • Biomrieux Inc
  • Bio-Rad Laboratories
  • Cardinal Health
  • Cenogenics Corporation
  • CTK Biotech Inc.
  • Diasorin S P A
  • Eiken Chemical Co. Ltd.
  • Epitope Diagnostics Inc.
  • Exact Sciences Corp.
  • F. Hoffmann-La Roche Ltd.
  • Genova Diagnostics
  • Meridian Bioscience Inc
  • Pinnacle BioLabs
  • Prenetics Group Limited
  • QIAGEN
  • Others

GLOBAL GI STOOL TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019-2032

  • Bacteria tests
  • Fecal biomarker tests
  • Occult blood tests
  • Others

GLOBAL GI STOOL TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Infectious diseases
  • Inflammatory bowel disease
  • Gastroesophageal Reflux Disease (GERD)
  • Cancer
  • Others

GLOBAL GI STOOL TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital & clinics
  • Diagnostic centers
  • Homecare
  • Others

GLOBAL GI STOOL TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. GI Stool Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. GI Stool Testing Market Snippet by Test Type
    • 2.1.2. GI Stool Testing Market Snippet by Application
    • 2.1.3. GI Stool Testing Market Snippet by End User
    • 2.1.4. GI Stool Testing Market Snippet by Country
    • 2.1.5. GI Stool Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. GI Stool Testing Key Market Trends

  • 3.1. GI Stool Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. GI Stool Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. GI Stool Testing Market Opportunities
  • 3.4. GI Stool Testing Market Future Trends

4. GI Stool Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. GI Stool Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. GI Stool Testing Market Landscape

  • 6.1. GI Stool Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. GI Stool Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Bacteria tests
    • 7.1.3. Fecal biomarker tests
    • 7.1.4. Occult blood tests
    • 7.1.5. Others

8. GI Stool Testing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Infectious diseases
    • 8.1.3. Inflammatory bowel disease
    • 8.1.4. Gastroesophageal Reflux Disease (GERD)
    • 8.1.5. Cancer
    • 8.1.6. Others

9. GI Stool Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital & clinics
    • 9.1.3. Diagnostic centers
    • 9.1.4. Homecare
    • 9.1.5. Others

10. GI Stool Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. GI Stool Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. GI Stool Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. GI Stool Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. GI Stool Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. GI Stool Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- GI Stool Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AdvaCare Pharma
    • 11.2.2. Biomrieux Inc
    • 11.2.3. Bio-Rad Laboratories
    • 11.2.4. Cardinal Health
    • 11.2.5. Cenogenics Corporation
    • 11.2.6. CTK Biotech Inc.
    • 11.2.7. Diasorin S P A
    • 11.2.8. Eiken Chemical Co. Ltd.
    • 11.2.9. Epitope Diagnostics Inc.
    • 11.2.10. Exact Sciences Corp.
    • 11.2.11. F. Hoffmann-La Roche Ltd.
    • 11.2.12. Genova Diagnostics
    • 11.2.13. Meridian Bioscience Inc
    • 11.2.14. Pinnacle BioLabs
    • 11.2.15. Prenetics Group Limited
    • 11.2.16. QIAGEN
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us